
Promega Corporation
Free shipping on orders over $99 · 30-day returns
OncoMate MSI Dx Analysis System is an FDA 510(k)-cleared medical device (K200129) manufactured by Promega Corporation. This device is classified under the Immunology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on July 25, 2021. Regulation: 8.